April 28, 2017
Recommended Topic Related To:

Nasalide

"The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a hi"...

A A A

Nasalide

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)




Overdosage
Contraindications

OVERDOSE

In mice, rats and dogs, intravenous flunisolide at doses up to 4 mg/kg showed no effect. One spray bottle contains 6.25 mg of flunisolide; therefore, acute overdosage is unlikely.

CONTRAINDICATIONS

Hypersensitivity to any of the ingredients. NASAREL should not be used in the presence of untreated localized infection involving the nasal mucosa.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/8/2004

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.